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Borna disease virus (BDV) is a noncytolytic, neurotropic RNA virus that causes a chronic neurological disease in a wide
variety of animal species. To develop a better understanding of the correlation between neurological disorders caused by
BDV infection and virus distribution in the brain, we investigated viral dynamics in the central nervous system (CNS) of
neonatally BDV-infected gerbils during the late stage of infection. Despite the severe symptoms and aggressive proliferation
of BDV in the infected gerbils, no apparent neuroanatomical abnormalities or neuronal cell loss was observed in the infected
gerbil brain. Furthermore, no or only minimal infiltration was observed in the infected gerbil brain. By in situ hybridization and
real-time PCR analyses, we demonstrated that the predominant area of expression of BDV mRNA, as well as the protein, was
shifted in the brain in association with progression of disease. In nondiseased gerbils, the virus replication was predomi-
nantly detected in the cerebral cortex and hippocampus of the CNS. On the other hand, diseased animals showed a high level
of expression in the lower brain stem and cerebellum, especially in Purkinje cell neurons. These observations suggested that
significant replication of the virus in specific areas of the CNS is critical for development of the neurological disorders in
BDV-infected neonatal gerbils. © 2001 Academic PressINTRODUCTION
Borna disease virus (BDV) is a neurotropic negative-
strand RNA virus that infects many vertebrates, including
horses, sheep, cats, and primates, and causes central
nervous system (CNS) diseases characterized by behav-
ioral and locomotor abnormalities (Bode et al., 1994;
Lundgren et al., 1995; Rott and Becht, 1995; Hagiwara et
al., 1997; Nakamura et al., 1999b). Recent epidemiologi-
cal studies using peripheral blood or brain samples
revealed that BDV can infect humans and that it may be
related to certain neuropsychiatric disorders (Sauder et
al., 1996; Waltrip et al., 1997; Nakamura et al., 2000).
Rats are frequently used for pathological analysis of
BDV in the CNS. Infection of adult Lewis rats by BDV
induces neurological disease, which is associated with
host immune responses. Marked perivascular or menin-
geal infiltration of mononuclear cells was observed in the
infected rat brain (Narayan et al., 1983; Stitz et al., 1995;
Lewis et al., 1999). It has been demonstrated that the
neurological symptoms in these rats are due to degen-
eration of neuronal cells by cytotoxic T lymphocytes
(CTL), which recognize virus-specific antigens (Planz and
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65Stitz, 1999). In contrast, neonatally BDV-infected rats do
not show any immunopathological changes in the brain,
because the rats establish immunological tolerance to
BDV (Hirano et al., 1983; Carbone et al., 1991). It has been
reported, however, that BDV-infected neonatal rats de-
velop abnormalities in affective behavior and neuroana-
tomical disturbances characterized by degeneration of
hippocampal neurons, cortical shrinkage, cerebellar hy-
poplasia, and degeneration of Purkinje cell neurons of
the cerebellum (Carbone et al., 1991; Bautista et al., 1995;
Eisenman et al., 1999; Rubin et al., 1999a,b; Gonzaletz-
Dunia et al., 2000). Furthermore, chronic astrocytosis and
microgliosis, as well as a progressive decrease in syn-
aptic density and plasticity, were observed in the brains
of neonatally infected rats (Hornig et al., 1999; Sauder
and de la Torre, 1999; Gonzaletz-Dunia et al., 2000).
Recently, we reported experimental infection of the Mon-
golian gerbil with BDV (Nakamura et al., 1999a). Our
studies demonstrated that gerbils are highly susceptible
to BDV and also that proliferation of BDV in neonatal
gerbil seems to be more active than that in neonatal rats
(Nakamura et al., 1999a, 2000). Further, neonatally in-
fected gerbils developed acute and fatal neurological
diseases, characterized by locomotor abnormalities with
no significant neuroanatomical disturbance. Thus, BDV-
infected neonatal gerbils could provide a useful model in
which to analyze the direct effects of BDV infection in the
brain.
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66 WATANABE ET AL.BDV is a noncytolytic virus that readily establishes
persistent infection in cultured cells. The BDV anti-
genome encodes at least six different proteins. Of these,
nucleoprotein (p40) and phosphoprotein (p24) are major
products of BDV and are abundantly found in the brains
of both naturally and experimentally infected animals
(Bause-Niedrig et al., 1991, 1992). Although the precise
mechanisms by which BDV causes neurological disor-
ders have not been determined, expression and accu-
mulation of these abundant viral proteins in the infected
brain must be involved in the pathogenesis of BDV in
both immune system-dependent and -independent
mechanisms. Furthermore, despite the fact that virus
infection in specific areas of the CNS must be involved in
the appearance of specific disorders, the details of the
viral load of BDV in infected brains have not been fully
elucidated.
In this study, we investigated the dynamics of the
expression of BDV-p40 and -p24 mRNAs and antigens
in the brains of neonatally infected gerbils during the
late stage of virus infection. Despite the severe symp-
toms and aggressive proliferation of BDV in the in-
fected gerbils, only minimal infiltration was observed
in the brain. Furthermore, the predominant area of BDV
mRNA, as well as protein, was shifted in the brain in
association with progression of disease. These obser-
vations indicate that significant expression of the virus
in specific brain regions is critical for the development
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nRESULTS
Clinical characteristics of BDV-infected gerbils
To investigate the process of multiplication of BDV in
the brain, we inoculated a low titer of BDV (0.2–200
focus-forming units (FFU)/animal) into a total of 74 neo-
natal gerbils. None of the gerbils inoculated with 0.2 FFU
of BDV showed any clinical signs over the observation
period. Of the 7 gerbils inoculated with 2 FFU of BDV,
only 1 developed paralysis of the hind legs at 28 days
postinoculation (dpi) (Table 1). On the other hand, almost
all gerbils inoculated with 20 or 200 FFU of BDV devel-
oped clinical disease, characterized by the paralysis of
the hind legs with significant body weight loss until 30
dpi (Fig. 1 and Table 1). In addition, quadriparesis, hy-
popraxia, debility, or blindness was induced after onset
of the disease in some of the gerbils. During the obser-
vation period, none of the gerbils recovered from the
disease. Inoculation with 2000 FFU of BDV yielded the
same course of disease as inoculation with 200 FFU
(data not shown). All of the diseased gerbils died by day
40 postinfection.
Detection of antibodies against BDV major antigens in
the sera of infected gerbils
Previous studies have demonstrated that neonatally
BDV-infected rats produce antibodies to BDV at the per-
sistent stage of the infection (Carbone et al., 1991). Thus,
ulated with BDV
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67VIRAL DYNAMICS IN BDV-INFECTED NEONATAL GERBILSinfected gerbils were detected by Western blotting using
recombinant p40 and p24 antigens. As shown in Fig. 2,
antibodies to p24 were detected in the sera from all of
the gerbils that developed clinical symptoms, and the
reactivity gradually increased for up to 30 dpi (Fig. 2 and
Table 1). Antibodies to p10 were also detectable in all the
sera that reacted with p24 antigen (data not shown). On
the other hand, antibody reactive with recombinant p40
was detectable only in serum from a 20-FFU-inoculated
gerbil at 30 dpi (data not shown).
Pathological alterations in the brain of BDV-infected
gerbils
No gross neuroanatomical disturbances or immuno-
pathological changes were observed in the brains of the
neonatally infected gerbils during the observation period
of 30 days. Cerebellar hypoplasia or degeneration of the
dentate gyrus, common features in BDV-infected neona-
tal rats, was not found even in the diseased gerbils (Fig.
3A). On the other hand, minimal perivascular and men-
ingeal infiltration was found by hematoxylin–eosin (HE)
staining in the cerebral cortex, brain stem, and cerebel-
lum of the gerbils at 25 or 30 or at 30 dpi with 200 and 20
FFU, respectively (Table 1 and Fig. 3A). However, we
found no correlation between these alterations and the
neurological disease in the gerbils. Some gerbils that
showed severe fatal disease developed no immuno-
pathological changes in the brain (Table 1). Further, neu-
FIG. 1. Onset of neurological disease in BDV-infected neonatal gerb
birth, and body weight and clinical symptoms of the gerbils were obser
with uninfected cells (A) and 200 (B), 20 (C), 2 (D) diseased, (E) nondisea
of neurological symptoms.ils. Newborn gerbils were inoculated with a low titer of BDV within 24 h after
ved at 3- or 4-day intervals. Body weights of representative gerbils inoculatedropathological lesions were not observed in the spinal
cord of infected gerbils (data not shown).FIG. 2. Detection of anti-BDV antibodies in sera of infected gerbils.
Anti-p40 and -p24 antibodies in gerbil sera were detected by Western
blotting using GST-p40 (A) and -24 (B) antigens. Sera from 200-FFU-
inoculated gerbils at 20 (lanes 1 and 2), 25 (lanes 3 and 4), and 30 dpi
(lanes 5 and 6). P, BDV-infected rat serum; MI, mock-infected gerbil
serum at 30 dpi. Data on representative animals that developed the
disease are shown.
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68 WATANABE ET AL.To investigate whether neonatal BDV infection leads to
synaptic and neuronal damage, sections from the BDV-
infected gerbils were immunostained with anti-microtu-
bulin-associated protein 2 (MAP-2) antibody (Fig. 3B).
The antibody stained the neuronal cells and neuropil in
the brains of the BDV-infected gerbils with almost the
same densities as those of mock-infected gerbils in each
specific region, including the cerebral cortex, hippocam-
pus, and cerebellum (Fig. 3B). Furthermore, we investi-
gated apoptotic signals in brain sections from infected or
mock-infected gerbils by TUNEL assay. Consequently, no
significant differences in apoptotic signals between BDV-
infected and uninfected gerbil brains were observed
(data not shown), indicating that the neuronal cells
seemed not to be much damaged by the infection in the
neonatal gerbils.
Expression dynamics of the BDV transcripts in the
BDV-infected gerbil brain
To assess the replication of BDV in the infected brain,
BDV p40 and p24 expressions were analyzed by North-
ern blotting and antigen capture enzyme-linked immu-
nosorbent assay (ELISA). The total RNAs and proteins
were extracted from whole brains. As shown in Fig. 4,
BDV-specific mRNAs were found in the brains of almost
all gerbils, except those inoculated with a dose of 0.2
FIG. 3. Histological analysis of brains from BDV-infected gerbils at
erebellum (e and f) of mock-infected gerbils (a, c, e) and BDV-infect
ntibody staining. Enlargements of a perivascular infiltration area in the
hown as insets in b, e, and f. Bars, 100 mm (A, a–d; B, a–f) and 500 mFFU (Fig. 4 and Table 1). The viral mRNAs were detected
at comparable levels in the brains of each group at 20dpi (Fig. 4). Furthermore, the infected brains contained
almost the same levels of major BDV proteins (Table 1),
indicating that the virus actively grew to comparable
levels in the brains of diseased and nondiseased ani-
mals.
To investigate the correlation between the expression
of the BDV antigens in specific brain regions and devel-
opment of neurological disease in the neonatal gerbils,
we next examined the dynamics of expression of viral
mRNAs in the infected brains by in situ hybridization
(ISH) with BDV p40 and p24 antisense and sense probes.
First, to assess the sensitivities of the riboprobes used in
this study, we carried out RNA dot blot assay with in
vitro-transcribed RNAs as targets for the probes. All
probes showed almost the same level of sensitivity. The
probes could specifically detect amounts of target RNAs
as low as 78 ng (data not shown).
Using these probes, the distributions of viral mRNAs in
each brain region from the 20- and 200-FFU-infected
gerbils were analyzed. The levels of mRNA expression in
specific brain areas were also estimated from the optical
density of the positive signals. In the gerbils inoculated
with 200 FFU of BDV, positive signals of the BDV mRNAs
were predominantly seen in the cerebral cortex, hip-
pocampus, diencephalon, and medulla of the cerebellum
at 20 dpi (Fig. 5A). In contrast, diseased gerbils showed
Cerebral cortex (frontal lobe) (a and b), hippocampus (c and d), and
ased gerbils (b, d, f). (A) Hematoxylin and eosin and (B) anti-MAP-2
ral cortex (bar, 20 mm) and structure of Purkinje layer (bar, 40 mm) are
e and f).30 dpi.
ed disehigh levels of expression in the lower brain stem, includ-
ing the midbrain, medulla oblongata and pons, and cer-
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69VIRAL DYNAMICS IN BDV-INFECTED NEONATAL GERBILSebellum (Fig. 5A). The mRNAs appeared in the Purkinje
cells of the cerebellum only after onset of disease (Fig.
5A, arrows). The nondiseased animals that were sacri-
ficed at 30 dpi expressed low levels of the mRNAs in the
lower brain stem and Purkinje cells (Fig. 5B, a and b).
Furthermore, the sense probe stably detected the BDV
genomic RNA in almost all regions in which unbalanced
expression between p40 and p24 mRNAs was detected
(Fig. 5C). The gerbils inoculated with 20 FFU revealed a
distribution of the mRNAs in the CNS similar to that of
200-FFU-inoculated gerbils. The 20-FFU-inoculated ger-
bils showed expression of the mRNAs predominantly in
the lower brain stem and cerebellum at 30 dpi, when the
gerbils developed neurological disease (data not
shown). Analysis of the optical density of the positive
signals revealed the same dynamics of the mRNA ex-
pression patterns in the brain. Expression of the mRNAs
in the cerebral cortex and hippocampus was gradually
decreased up to 30 dpi (Fig. 5D). The density of the p40
transcript was also decreased in the diencephalon (Fig.
5D). On the other hand, the levels of the mRNAs in-
creased in the lower brain stem and lobule of the cere-
bellum in association with the appearance of disease
(Fig. 5D). In addition, the density was relatively stable in
the medulla of the cerebellum throughout the observa-
tion period (Fig. 5D).
To confirm the correlation between expression of viral
mRNA and protein in the brain, sections were also im-
munostained with anti-p40 and -p24 antibodies. As
shown in Fig. 6, the number of cells positive for the BDV
antigens was decreased in the hippocampus, but immu-
noreactivity appeared in the Purkinje cells of the cere-
bellum (arrows) after the onset of the disease, confirming
the results of ISH analysis.
Quantification of BDV mRNAs in specific
brain regions
FIG. 4. Detection of BDV mRNAs in infected gerbil brains. Total RNA
analyzed by Northern blotting using full-length (A) p40 and (B) p24 antFor further confirmation, we quantified levels of ex-
pression of BDV p40 and p24 mRNAs in selected brain
t
sregions of diseased and nondiseased gerbils by real-
time PCR assay as described under Materials and Meth-
ods. Correlation efficiency of the calculation curve of the
control DNA versus the threshold cycle (C T) value was
qual to 0.99 in the range of 4 3 104 to 4 3 101 and 8 3
104 to 8 3 101 copies of p40 and p24 sense cDNAs,
espectively. The standard curve for quantitation of p40
nd p24 mRNAs in infected brains was generated by
erial 10-fold dilutions of 4 3 104 and 8 3 104 copies of
40 and p24 cDNAs, respectively.
As expected, changes in the levels of the p40 and p24
RNAs were also observed. We detected a relatively
igh level of expression in the cerebral cortex of the
ondiseased gerbil brain at both 25 and 30 dpi compared
ith the brains from diseased gerbils (Fig. 7A). The levels
f the mRNAs were clearly increased in the cerebellum
fter onset of disease (Fig. 7A). The expression of the
RNAs was detected at similar levels in almost all ani-
als we analyzed. This result was consistent with those
f ISH analysis. Furthermore, quantitative antigen-cap-
ure ELISA also showed increased levels of the major
iral antigens in the cerebellum of the diseased animals
Fig. 7B). These results suggested that significant ex-
ression of the virus in specific CNS areas might be
ssociated with development of neurological disease in
he neonatal gerbils.
DISCUSSION
In this study, we demonstrated that BDV-infected neo-
atal gerbils develop acute and fatal neurological dis-
ase. However, the gerbils did not show degeneration of
ippocampal neurons or hypoplasia of the cerebellum
hat is usually found in the brains of neonatally BDV-
nfected rats (Fig. 3). In addition, although large numbers
f apoptotic cells were observed in the brain of infected
ats (Hornig et al., 1999), we could not find significant
ifference in apoptotic signals between the infected and
isolated from brain hemispheres. Aliquots of 5 mg of total RNA were
riboprobes. MI, RNA from mock-infected gerbil brain.he uninfected gerbil brains, suggesting that there is no
ignificant pathological alteration in the brains of BDV-
(l wn at t
a .
70 WATANABE ET AL.infected gerbils in this study. It is still possible, however,
that the BDV infection induced pathological changes in
specific areas of CNS. The detailed analysis using anti-
bodies specific for gerbil would be necessary for assess-
ment of neuroanatomical alterations in the infected ger-
bil brains.
Our analysis also revealed that the infected neonatal
gerbils seemed to show no immunological tolerance to
BDV, even when inoculated on postnatal day one (PND-
1), because antibodies to the p24 and p10 proteins, but
not to the p40, were detected in these animals (Fig. 2).
Some gerbils did not show inflammatory response in the
brains, suggesting a possibility that the gerbils develop a
split tolerance to the virus. It is noteworthy that adult
FIG. 5. Analysis of BDV-specific RNA expression in infected gerbil br
brains at 20, 25, and 30 dpi. The sections from 25 and 30 dpi represe
(parietal lobe); (d–f) hippocampus (Ammon’s horn); (g–i) diencephalo
medullare cerebelli; (p–r) lobule of cerebellum. Probes used for ISH are
a–i, m–o) and 60 mm (j–l, p–r). (B) Expression of p24 mRNA in the lowe
Bars, 60 mm. (C) Detection of genomic RNA in the infected gerbil brai
infected gerbil brain. The optical density of the positive signals was m
east four sections from each animal. Specific regions examined are sho
re also shown (bars). (a) p40 antisense and (b) p24 antisense probesgerbils infected with BDV also produce no or only low
levels of anti-p40 antibodies (data not shown). This find-ing suggests that BDV p40 may be difficult to recognize
for the host immune system in gerbils. Previous studies
have indicated that the immune reaction against p40
protein is necessary for induction of encephalitis in BDV-
infected rats (Planz and Stitz, 1999). Although we did not
examine CTL response to BDV antigens in the infected
gerbils, a weak response to p40 in the animals may be
involved in the pathological difference between BDV-
infected gerbil and rat brains. A recent study demon-
strated that vulnerability of the CNS to BDV infection is
dependent on the developmental stage of the brain (Ru-
bin et al., 1999a). BDV infection of PND-15 rats resulted in
persistent infection associated with body weight stunting
and hippocampal neuron degeneration, similar to rats
in situ hybridization. (A) Distribution of BDV mRNAs in infected gerbil
ns of gerbils that showed neurological disease. (a–c) Cerebral cortex
thalamus); (j–l) lower brain stem (medulla oblongata); (m–o) corpus
n at the top. Arrows, Purkinje cells with positive signals. Bars, 100 mm
stem (a) and cerebellum (b) of infected nondiseased gerbils at 30 dpi.
al lobe) at 30 dpi. Bars, 100 mm. (D) Dynamics of BDV mRNAs in the
d in one to three different 0.4-mm2 fields of each specific region in at
he top. The averages of each group classified by the time after infectionains by
nt brai
n (hypo
show
r brain
n (front
easureinoculated with BDV on PND-1. However, unlike rats
infected with BDV on PND-1, rats inoculated on PND-15
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71VIRAL DYNAMICS IN BDV-INFECTED NEONATAL GERBILSdid not show signs of cerebellar hypoplasia or hyperac-
tivity (Rubin et al., 1999a). Rats inoculated on PND-1
developed persistent BDV infection of Purkinje cells dur-
ing cerebellar development, resulting in abnormal cere-
bellar growth, including loss of granule cells (Bautista et
al., 1995; Eisenman et al., 1999). In infection of PND-1
erbils, however, persistent infection of BDV in Purkinje
ells was identified between 25 and 30 days after inoc-
lation, when the cerebellum has already matured. Thus,
he degree of immune system and/or CNS maturation of
erbils at birth might contribute to neuroanatomical dif-
erences between the infected gerbil and the infected rat
FIG. 5nd therefore might be important determinants of the
utcome of disease.Viruses can change their target regions in the CNS in
association with the stage of infection. Changes in viral
distribution dependent on the stage of disease have
been reported in the case of canine distemper virus
(Bernard et al., 1993) and rabies virus (Ugolini, 1995).
urthermore, a subacute sclerosing panencephalitis
train of measles virus is found primarily in the rhinen-
ephalon, limbic system, and striatum in the infected
ouse brain (Roos et al., 1978; Love et al., 1986). Our
results also indicated that the predominant regions of
BDV replication in the infected gerbil brains shifted dur-
ing the late stage of infection (Fig. 5). In the nondiseased
inuedphase, the virus mRNAs were prominently detected in
the cerebral cortex, hippocampus, diencephalon, and
) cerebellum. Positive Purkinje cells are indicated by arrows. All sections were
).
72 WATANABE ET AL.medulla of the cerebellum. However, the mRNAs were
predominantly detected in the lower brain stem and
cerebellum, especially in the Purkinje cells, of the dis-
eased gerbil brain. The decrease in level of viral mRNA
in specific regions seemed not to be due to the degen-
eration or disturbance of the neuronal cells, because
neuronal cell density was not affected by infection in the
brain, even in the diseased animals (Fig. 3B). In addition,
the virus genomic RNA was stably detected in the gerbil
brain over the observation period (Fig. 5C), indicating
that BDV can change the level of viral expression in
specific brain areas in association with the stage of
infection. Interestingly, it has been reported that BDV
appeared in the medulla of infected rats in advance of
the cerebral cortex and hippocampus and the disease
onset was linked to the appearance of the virus in the
hippocampus (Carbone et al., 1987). This might be due to
the difference of the inoculation route between the gerbil
and the rat models. The rats were inoculated by the
footpad route.
Different neuronal populations or areas in the CNS
must differ in vulnerability to viral infections. Therefore,
noncytolytic virus infections can result in localized alter-
ations or neurological disorders caused by disturbance
of specialized functions of neuronal cells in specific
brain regions (Smart and Charlton, 1992). Recently, re-
FIG. 6. Detection of BDV major proteins in the brains of nondiseased
anti-p40 polyclonal antibody (brown). (a and b) Cerebral cortex, (c and d
counterstained with hematoxylin. Bars, 100 mm (a, b) and 40 mm (c, d(a, c) and diseased (b, d) gerbils. The infected gerbil brains were stained withstricted BDV expression and neurological lesions in the
septum, hippocampus, amygdala, and hypothalamusFIG. 7. Quantification of BDV p40 and p24 mRNAs and antigens in the
infected gerbil brain. Total RNAs and proteins were isolated from the
selected brain regions from 200-FFU-inoculated nondiseased and dis-
eased gerbils at 25 or 30 dpi and analyzed by real-time PCR (A) and
antigen-capture ELISA (B), respectively. Each bar shows the result of at
least three independent measurements of a representative animal in
each case. ND, nondiseased gerbils; D, diseased gerbils. Selected
brain areas are shown at the top.
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73VIRAL DYNAMICS IN BDV-INFECTED NEONATAL GERBILShave been reported in rats infected with a variant of BDV.
These rats developed a rapid increase in body weight
with the development of an obesity syndrome without
obvious neurological signs (Herden et al., 2000). In ad-
ition, neonatally BDV-infected rats developed synaptic
lterations only in the cortex and hippocampus, although
he virus antigen was present in virtually all brain regions
Rubin et al., 1999b; Gonzaletz-Dunia et al., 2000). These
observations indicated that viruses could induce local-
ized damage in the CNS and cause neurological disor-
ders that are associated with the regions of the alter-
ations.
In this experiment, we observed significant paralysis
of the hind legs with or without quadriparesis or hy-
popraxia in neonatal gerbils. However, histological anal-
ysis demonstrated that the signs of neurological disease
in the infected gerbils were not due to neuronal or axonal
damage of the spinal cord, indicating that the disorders
were caused by CNS damage. It is likely that significant
replication of BDV in the lower brain stem and Purkinje
cells contributes to onset of the disease in the gerbils.
This was strongly supported by the following observa-
tions. First, the level of viral replication in the brains of
diseased animals was comparable to that in nondis-
eased animals (Fig. 4 and Table 1). Second, although a
number of gerbils showed no or only minimal infiltration
of lymphocytes in the cerebral cortex or brain stem,
these alterations were not necessarily correlated with
neurological disease (Fig. 3 and Table 1). Third, BDV
infection seemed not to induce remarkable decrease of
neuronal cell or other morphological alteration in the
brains of diseased gerbils (Fig. 3). Fourth, none of the
diseased gerbils showed low levels of expression of BDV
mRNAs in the lower brain stem and Purkinje cells (Figs.
5 and 7). On the other hand, the viral mRNAs exhibited
similar dynamics in the other brain regions of both dis-
eased and nondiseased gerbils. Thus, productive repli-
cation of the virus in the lower brain stem and Purkinje
cells may be critical for the onset of disease in neonatal
gerbils. The expression or accumulation of the major
virus antigens might lead to impairment in neuronal
interactions by modifying trafficking of the brain factors
required for proper neuronal functions, in the absence of
neuronal cell destruction. Indeed, a correlation between
a high level of viral antigen expression in Purkinje cells
and development of neurological disease has been re-
ported in the case of infection with neurotropic viruses
such as lymphocytic choriomeningitis virus (Rodriguez et
al., 1983). Further studies are currently in progress to
identify which brain factors are involved in the functional
disorder of the neuronal cells of the BDV-infected gerbil
brain. Finally, quantitative antigen-capture ELISA demon-
strated that the level of the p24 antigen was higher than
that of p40 in the cerebellum of the diseased gerbils (Fig.
7B). Our recent study also revealed that a persistently
BDV-infected cell line contains a higher ratio of p24antigen compared with acutely infected cells (Watanabe
et al., 2000b). Furthermore, there have been reports on
naturally BDV-infected patients showing nonparallel de-
tection of p40 and p24 antigens (Nakamura et al., 2000)
or antibodies (Yamaguchi et al., 1999). These observa-
tions suggested that the BDV antigens might show dif-
ferences in turnover or accumulation in the infected
cells. The injury of neuronal cells by the accumulation of
specific BDV antigens should be further investigated to
determine the neuropathogenesis of BDV.
MATERIALS AND METHODS
Virus stock
The C6 (rat glioma) cell line persistently infected with
BDV strain He/80 (C6/BV) (Cubitt et al., 1994) was used
as a virus source. For preparation of virus stock, C6/BV
was suspended in phosphate-buffered saline (PBS) and
lysed by sonication followed by freezing and thawing.
Titration of BDV
Infectious titer of the virus stock was measured as
follows. Semiconfluent monolayers of C6 cells in glass-
bottomed dishes were maintained with Dulbecco’s mod-
ified Eagle’s medium and inoculated with serial dilutions
of the virus stock. Three days after inoculation, the cells
were fixed with 4% paraformaldehyde for 10 min, perme-
abilized for 5 min with 0.4% Triton X-100, and analyzed by
indirect immunofluorescence assay using the p40 poly-
clonal antibody (PoAb). The virus titer was calculated by
assuming that each focus of fluorescent cells originated
from infection with a single replication-competent virus
particle as FFU per milliliter of the cell lysate.
BDV infection of gerbils and sample preparation
Neonatal Mongolian gerbils (SLC, Shizuoka, Japan)
were inoculated intracranially (into the subarachnoid
cavity at the temporal position) with 0.2 to 200 FFU of
BDV stock per animal within 24 h after birth. Sham
inoculation was performed with injection of uninfected
C6 cell lysate. The body weight and clinical symptoms of
gerbils were observed at 3- or 4-day intervals.
Gerbils were sacrificed at 20, 25, and 30 dpi, and the
sera, brains, and spinal cord were collected for analyses.
For histological analysis, the right hemisphere of the
brains and spinal cord were fixed with 4% paraformalde-
hyde overnight at 4°C and embedded in paraffin. Whole
or selected regions (frontal lobe, parietal lobe, optical
lobe, temporal lobe, internal brain, cerebellum, and lower
brain stem) of the left hemisphere were homogenized
and used for total RNA or protein extraction.
Western blottingRecombinant BDV p40 and p24 proteins were ex-
pressed as glutathione-S-transferase (GST) fusion pro-
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74 WATANABE ET AL.teins in Escherichia coli and purified by affinity column
chromatography with Sepharose 4B (Amersham Pharma-
cia Biotech, Uppsala, Sweden) as described previously
(Bahmani et al., 1996). The purified proteins were then
eparated by sodium dodecyl sulfate (SDS)–polyacryl-
mide gel electrophoresis and transferred onto polyvi-
ylidene difluoride membranes. The membrane strips
ere incubated with 100-fold dilution of gerbil sera in 3%
kimmed milk in PBS for 1 h at room temperature. Re-
cted antibodies were visualized using Konica immuno-
tain HRP-1000. As a positive control, BDV-infected rat
erum (Watanabe et al., 2000a) was used.
istological study of gerbil brain and spinal cord
Thin sections (4 mm) of gerbil brains were stained with
HE for histological evaluation by light microscopy.
Immunohistochemistry
Deparaffinized thin sections (4 mm) were incubated
with trypsin solution (0.1% trypsin, 0.1% CaCl2, 0.05 M
ris–HCl, pH 7.6) for 30 min at 37°C. Endogenous per-
xidase was quenched with 0.5% HIO4. The sections
ere then incubated with rabbit anti-p40 or -p24 PoAb
1:2000 dilution in PBS) or anti-MAP-2 antibody overnight
t 4°C. After several washes, primary antibodies were
etected by incubation with biotinylated goat anti-rabbit
gG (1:200 dilution in PBS (Vector, Burlingame, CA)).
hereafter, the sections were incubated with the avidin–
iotin peroxidase complex (1:125 dilution in PBS (Vec-
or)). Specific reactions were visualized with 3,39-diami-
obenzidine tetrahydrochloride.
iboprobes
Full-length BDV p40 or p24 cDNAs were amplified
sing RNA from MDCK cells persistently infected with
DV (Herzog and Rott, 1980) by PCR and inserted into the
olycloning site of pBluescript II SK(2). The plasmid
NAs were linearized with BamHI (for p40 antisense and
24 sense and antisense probes) and NotI (for p40
ense probe), and digoxigenin (DIG)-labeled riboprobes
ere synthesized using a DIG RNA labeling kit (Boehr-
nger Mannheim, Germany). The pSTP18-neo plasmid
ontaining the bacterial neomycin transferase (Neo)
ene was used to generate negative control ribo-
robes. Riboprobes for ISH were processed by alkaline
ydrolysis.
Sensitivity of all riboprobes was assessed by Northern
RNA) dot blot analysis. Unlabeled sense or antisense
DV p40 or p24 RNA was synthesized from template with
n vitro transcription using T7 polymerase as described
bove. After treatment with DNase I, the products were
erially diluted and blotted onto nylon membranes. The
lotted RNAs were hybridized with 0.1 mg/ml DIG-labelediboprobes in high-SDS-hybridization buffer (7% SDS,
0% formamide, 53 SSC, 0.1% N-lauroylsarcosine, 50M sodium phosphate (pH 7.0), 2% blocking reagent
Boehringer Mannheim)). The hybridized probes were
etected with alkaline phosphatase-conjugated anti-DIG
ab fragments (Boehringer Mannheim) and were visual-
zed with the chemiluminescence substrate CSPD
Boehringer Mannheim). The specific signals were re-
orded on X-ray film.
orthern blotting
Total RNA was extracted from the brain homogenates
sing an RNA isolation kit (Isogen, Nippon Gene Co.,
okyo, Japan). Aliquots of 5 mg of total RNA were elec-
rophoresed through 1% agarose–formaldehyde gels and
ransferred onto nylon membranes. The membranes
ere hybridized with p24 or p40 antisense DIG-labeled
iboprobes at 68°C overnight and processed as de-
cribed above.
SH
Thin sections (4 mm) of gerbil brains were deparaf-
inized and incubated in Tris–HCl, pretreated with 0.1
g/ml proteinase K in Tris–EDTA buffer for 20 min at
7°C, and fixed with 4% paraformaldehyde in Tris–HCl
pH 7.5). The sections were then incubated in hybridiza-
ion solution (50% formamide, 33 SSC, 50 mM Hepes
pH 7.0), 53 Denhardt’s solution, 250 mg/ml salmon
sperm DNA) for 30 min at 37°C and hybridized with
DIG-labeled riboprobes at a final concentration of 10
mg/ml for 16 h at 50°C. After hybridization, sections were
washed and incubated with alkaline phosphatase-la-
beled anti-DIG antibody. Specific signals were visualized
with nitroblue tetrazolium and X-phosphate (Boehringer
Mannheim).
For quantitative analysis of p40 and p24 mRNAs in the
infected brain, the optical density of the positive signal
was measured in one to three different 0.4-mm2 fields of
each specific region for at least four sections from each
animal. All optical density measurements were per-
formed under the same optical and lighting conditions
using MacScope software (MITANI Co., Fukui, Japan).
Real-time PCR assay
Quantification of BDV p40 and p24 mRNAs in the
brains of infected gerbils was carried out with specific
double fluorescently labeled probes and a 7700 Se-
quence Detector (PE Applied Biosystems, Norwalk, CT).
Taqman probes were labeled with 6-carboxy fluorescein
(FAM) as the 59 fluorescent reporter and tetramethylrho-
damine (TAMRA) as the 39 quencher. The primers and
probes used were as follows: p40-forward primer, 59-
TTTCATACAGTAACGCCCAGCC-39; p40-reverse primer,
59GGCGTCGACAGGTAAGATTCA-39; p40-probe, 59-FAM-
TGAACAAACGCAGCGTGCAGTCCT-TAMRA-39; p24-for-
ward primer, 59-ATGCATTGACCCAACCGGTA-39; p24-re-
verse primer, 59-ATCATTCGATAGCTGCTCCCTTC-39; and
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AGA-TAMRA-39.
Standard curves of the reactions were constructed
using cDNA from the uninfected gerbil brain containing
diluted full-length p40 or p24 sense cDNAs, which were
synthesized from in vitro-transcribed RNAs. The primers
used for reverse transcription (RT) were as follows: p24,
59-TTATGGTATGATGTCCCACTCATCCGTTGT-39, and p40,
59-TTAGTTTAGACCAGTCACACCTATCATTTTCATTATG-
CA-39.
The cDNA products were treated with RNase A and
ubjected to PCR. RT and PCR were carried out using a
aqMan Gold RT-PCR kit (PE Applied Biosystems).
riefly, aliquots of 0.2 mg of sample RNA were reverse
ranscribed with oligo(dT)16 in a final volume of 20 ml.
liquots of 5 ml of the resultant product were then used
for amplification with specific primers for BDV p40 or p24
in the presence of specific fluorogenic probes. Fluores-
cence intensity was detected with ABI Prism 7700 Se-
quence Detection system (PE Applied Biosystems).
Amount of first template was indicated as the C T, defined
as the number of cycles at which a significant increase
was first detected. Threshold was defined as the 10-fold
value of the average of the standard deviation of base-
line fluorescence intensity for early cycle. Quantity of the
target RNA was calculated from the standard curves.
Quantitative antigen-capture ELISAs
Antigen-capture ELISAs for the BDV p40 and p24 an-
tigens were described elsewhere (Watanabe et al.,
2000b). Briefly, microtiter plates coated with anti-p24 or
-p40 monoclonal antibody (MoAb) were incubated with
100 ml of diluted extracts from selected brain regions.
After being washed, the plates were incubated with rab-
bit anti-p24 or anti-p40 PoAb for 1 h at 37°C, followed by
addition of horseradish peroxidase-conjugated anti-rab-
bit IgG MoAb. After color development, the absorbance
was measured with a microplate reader at 492 nm. The
samples were regarded as positive if the value exceeded
three times the average of the negative reaction. Quan-
tity of viral protein was calculated from standard curves.
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